Cholesterol & Statins – the controversy continues
Albert Cilia-Vincenti A recent widely publicised Lancet review of statin efficacy and safety data generated more controversy than it resolved.1 Led by Professor Rory Collins of Oxford University, the review claimed that the benefits of statins have been underestimated and the risks exaggerated. Claims of…